Advertisement

Document › Details
Agilent Technologies Inc.. (9/18/19). "Press Release: Agilent Technologies Announces Cash Dividend of 16.4 Cents per Share". Santa Clara, CA.
![]() |
Organisation | Agilent Technologies Inc. (NYSE: A) |
![]() |
Product | analytical instrument |
Product 2 | diagnostics (medical/biological) | |
![]() |
Person | Dhingra, Ankur (Agilent 201903 IR) |
Person 2 | Beermann, Tom (Agilent 201907 Media Corporate) | |
Agilent Technologies, Inc. (NYSE: A) today announced that a quarterly dividend of 16.4 cents per share of common stock will be paid on Oct. 23, 2019 to all shareholders of record as of the close of business on Oct. 1, 2019.
The timing and amounts of future dividends are subject to determination and approval by Agilent's board.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics, and applied chemical markets. With more than 50 years of insight and innovation, Agilent instruments, software, services, solutions, and people provide trusted answers to its customers' most challenging questions. The company generated revenues of $4.91 billion in fiscal 2018 and employs 15,500 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to our Newsroom.
Follow Agilent on LinkedIn, Twitter, and Facebook.
Forward-Looking Statements
This news release contains forward-looking statements as defined in the Securities Exchange Act of 1934 and is subject to the safe harbors created therein. The forward-looking statements contained herein include, but are not limited to, information regarding the company's dividend program and future payment obligations. These forward-looking statements involve risks and uncertainties that could cause Agilent's results to differ materially from management's current expectations. Such risks and uncertainties are detailed in Agilent's filings with the Securities and Exchange Commission, including our quarterly report on Form 10-Q for the quarter ended July 31, 2019. Forward-looking statements are based on the beliefs and assumptions of Agilent's management and on currently available information. Agilent undertakes no responsibility to publicly update or revise any forward-looking statement.
Investor Contact
Ankur Dhingra
Agilent Technologies
+1 408 345 8948
ankur_dhingra@agilent.com
Media Contact
Tom Beermann
+1 408 553 2914
tom.beermann@agilent.com
Record changed: 2023-06-05 |
Advertisement

More documents for Agilent (Group)
- [1] Agilent Technologies Inc.. (9/5/23). "Press Release: Agilent Names Philip Binns to Lead Life Sciences and Applied Markets Group". Santa Clara, CA....
- [2] Illumina, Inc.. (9/5/23). "Press Release: Illumina's Board Appoints Jacob Thaysen, Ph.D. as its New Chief Executive Officer". San Diego, CA....
- [3] Agilent Technologies Inc.. (9/4/23). "Press Release: Agilent and ACTRIS Partner to Accelerate Cell and Gene Therapy in Singapore". Singapore....
- [4] Agilent Technologies Inc.. (6/12/23). "Press Release: Agilent Introduces New Comprehensive GPC/SEC Solutions at HPLC 2023 Conference". Santa Clara, CA....
- [5] Synthego Corporation. (5/17/23). "Press Release: Synthego Announces Invalidation of Agilent Patents in CRISPR Dispute". Redwood City, CA....
- [6] Agilent Technologies Inc.. (4/12/23). "Press Release: Agilent and PathAI Partner to Deliver AI-Powered Assay Development Solutions for Biopharma Research and Clinical Applications". Santa Clara, CA....
- [7] Agilent Technologies Inc.. (3/22/23). "Press Release: Agilent Honored with Asia Pacific Bioprocessing Excellence Award 2023 for Analytical Services". Singapore....
- [8] Agilent Technologies Inc.. (3/10/23). "Press Release: Agilent Announces Digital Pathology Scanner Distribution Agreement with Hamamatsu". Santa Clara, CA....
- [9] Agilent Technologies Inc.. (3/9/23). "Press Release: Agilent Announces Acquisition of e-MSion, Early-Stage Company Behind ECD Technology that Helps Accelerate Drug Development". Santa Clara, CA....
- [10] Agilent Technologies Inc.. (3/8/23). "Press Release: Agilent Announces Global Distribution Agreement with Proscia to Accelerate Data-Driven Precision Medicine". Santa Clara, CA....
To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com
Advertisement

» top